More than two decades of research indicate that the peptide neurotensi
n (NT) and its cognate receptors participate to a remarkable extent in
the regulation of mammalian neuroendocrine systems, potentially at mu
ltiple levels in a given system. NT-synthesizing neurons appear to exe
rt a direct or indirect stimulatory influence on neurosecretory cells
that synthesize gonadotropin-releasing hormone, dopamine (DA), somatos
tatin, and corticotropin-releasing hormone (CRH). In addition, context
-specific synthesis of NT occurs in hypothalamic neurosecretory cells
located in the arcuate nucleus and parvocellular paraventricular nucle
us, including distinct subsets of cells which release DA, CRH, or grow
th hormone-releasing hormone into the hypophysial portal circulation.
At the level of the anterior pituitary, NT stimulates secretion of pro
lactin and occurs in subsets of gonadotropes and thyrotropes. Moreover
, circulating hormones influence NT synthesis in the hypothalamus and
anterior pituitary, raising the possibility that NT mediates certain f
eedback effects of the hormones on neuroendocrine cells. Gonadal stero
ids alter NT levels in the preoptic area, arcuate nucleus, and anterio
r pituitary; adrenal steroids alter NT levels in the hypothalamic peri
ventricular nucleus and arcuate nucleus; and thyroid hormones alter NT
levels in the hypothalamus and anterior pituitary. Finally, clarifica
tion of the specific neuroendocrine roles subserved by NT should be gr
eatly facilitated by the use of newly developed agonists and antagonis
ts of the peptide. (C) 1997 Academic Press.